|
1.
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer Statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar
|
|
2.
|
Di Cosmo S and Baselga J: Management
breast cancer with targeted agents: Importance of heterogeneity.
Nat Rev Clin Oncol. 7:139–147. 2010.PubMed/NCBI
|
|
3.
|
Berry DA, Cronin KA, Plevritis SK, Fryback
DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD and
Feuer EJ: Cancer Intervention and Surveillance Modeling Network
(CISNET) Collaborators: Effect of screening and adjuvant therapy on
mortality from breast cancer. N Engl J Med. 353:1784–1792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Early Breast Cancer Trialists’
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
an overview of the randomised trials. Lancet. 365:1687–1717.
2005.PubMed/NCBI
|
|
5.
|
Adamo V, Iorfida M, Montalto E, Festa V,
Garipoli C, Scimone A, Zanghì M and Caristi N: Overview and new
strategies in metastatic breast cancer (MBC) for treatment of
tamoxifen-resistant patients. Ann Oncol. 18:53–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Liedtke C, Mazouni C, Hess KR, André F,
Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B,
Green M, Cristofanilli M, Hortobagyi GN and Pusztai L: Response to
neoadjuvant therapy and longterm survival in patients with
triple-negative breast cancer. J Clin Oncol. 26:1275–1281. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Petricoin EF III, Hackett JL, Lesko LJ,
Puri RK, Gutman SI, Chumakov K, Woodcock J, Feigal DW Jr, Zoon KC
and Sistare FD: Medical applications of microarray technologies: a
regulatory science perspective. Nat Genet. 32:474–479. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Nishidate T, Katagiri T, Lin ML, Mano Y,
Miki Y, Kasumi F, Yoshimoto M, Tsunoda T, Hirata K and Nakamura Y:
Genome-wide gene-expression profiles of breast-cancer cells
purified with laser microbeam microdissection: identification of
genes associated with progression and metastasis. Int J Oncol.
25:797–819. 2004.
|
|
10.
|
Komatsu M, Yoshimaru T, Matsuo T, Kiyotani
K, Miyoshi Y, Tanahashi T, Rokutan K, Yamaguchi R, Saito A, Imoto
S, Miyano S, Nakamura Y, Sasa M, Shimada M and Katagiri T:
Molecular features of triple negative breast cancer cells by
genome-wide gene expression profiling analysis. Int J Oncol.
42:478–506. 2013.PubMed/NCBI
|
|
11.
|
Hiruma T, Togayachi A, Okamura K, Sato T,
Kikuchi N, Kwon YD, Nakamura A, Fujimura K, Gotoh M, Tachibana K,
Ishizuka Y, Noce T, Nakanishi H and Narimatsu H: A novel human
beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique
carbohydrate structure, GalNAcbeta1-3GlcNAc. J Biol Chem.
279:14087–14095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hart GW and Copeland RJ: Glycomics hits
the big time. Cell. 143:672–676. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Fuster MM and Esko JD: The sweet and sour
of cancer: glycans as novel therapeutic targets. Nat Rev Cancer.
5:526–542. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Park JH, Nishidate T, Kijima K, Ohashi T,
Takegawa K, Fujikane T, Hirata K, Nakamura Y and Katagiri T:
Critical roles of mucin 1 glycosylation by transactivated
polypeptide N-acetylgalactosaminyltransferase 6 in mammary
carcinogenesis. Cancer Res. 70:2759–2769. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Park JH, Katagiri T, Chung S, Kijima K and
Nakamura Y: Polypeptide N-acetylgalactosaminyltransferase 6
disrupts mammary acinar morphogenesis through O-glycosylation of
fibronectin. Neoplasia. 13:320–326. 2011.PubMed/NCBI
|
|
16.
|
Potapenko IO, Haakensen VD, Lüders T,
Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC and
Børresen-Dale AL: Glycan gene expression signatures in normal and
malignant breast tissue; possible role in diagnosis and
progression. Mol Oncol. 4:98–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Park JH, Lin ML, Nishidate T, Nakamura Y
and Katagiri T: PDZ-binding kinase/T-LAK cell-originated protein
kinase, a putative cancer/testis antigen with an oncogenic activity
in breast cancer. Cancer Res. 66:9186–9195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kim JW, Akiyama M, Park JH, Lin ML, Shimo
A, Ueki T, Daigo Y, Tsunoda T, Nishidate T, Nakamura Y and Katagiri
T: Activation of an estrogen/estrogen receptor signaling by BIG3
through its inhibitory effect on nuclear transport of PHB2/REA in
breast cancer. Cancer Sci. 100:1468–1478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Shimo A, Nishidate T, Ohta T, Fukuda M,
Nakamura Y and Katagiri T: Elevated expression of protein regulator
of cytokinesis 1, involved in the growth of breast cancer cells.
Cancer Sci. 98:174–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Nogueira E, Fidalgo M, Molnar A, Kyriakis
J, Force T, Zalvide J and Pombo CM: SOK1 translocates from the
Golgi to the nucleus upon chemical anoxia and induces apoptotic
cell death. J Biol Chem. 283:16248–16258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Paulson JC and Colley KJ:
Glycosyltransferases. Structure, localization, and control of cell
type-specific glycosylation. J Biol Chem. 264:17615–17618.
1989.PubMed/NCBI
|
|
22.
|
El-Battari A, Prorok M, Angata K, Mathieu
S, Zerfaoui M, Ong E, Suzuki M, Lombardo D and Fukuda M: Different
glycosyltransferases are differentially processed for secretion,
dimerization, and autoglycosylation. Glycobiology. 13:941–953.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kato T, Suzuki M, Murata T and Park EY:
The effects of N-glycosylation sites and the N-terminal region on
the biological function of beta1,3-N-acetylglucosaminyltransferase
2 and its secretion. Biochem Biophys Res Commun. 329:699–705. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Brockhausen I: Pathways of O-glycan
biosynthesis in cancer cells. Biochim Biophys Acta. 1473:67–95.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Yoshida-Moriguchi T, Yu L, Stalnaker SH,
Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L and
Campbell KP: O-mannosyl phosphorylation of alpha-dystroglycan is
required for laminin binding. Science. 327:88–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Stevens E, Carss KJ, Cirak S, Foley AR,
Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, Feng L,
Haliloglu G, Orhan D, Dobyns WB, Enns GM, Manning M, Krause A,
Salih MA, Walsh CA, Hurles M, Campbell KP, Manzini MC; UK10K
Consortium; Stemple D, Lin YY and Muntoni F: Mutations in B3GALNT2
cause congenital muscular dystrophy and hypoglycosylation of
α-dystroglycan. Am J Hum Genet. 92:354–365. 2013.PubMed/NCBI
|
|
27.
|
Sgambato A, Migaldi M, Montanari M,
Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli
G, Trentini GP and Cittadini A: Dystroglycan expression is
frequently reduced in human breast and colon cancers and is
associated with tumor progression. Am J Pathol. 162:849–860. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Saito T, Miyoshi E, Sasai K, Nakano N,
Eguchi H, Honke K and Taniguchi N: A secreted type of
β1,6-N-acetylglucosaminyltransferase-V (GnT-V) induces tumor
angiogenesis without mediation of glycosylation. A novel function
of GnT-V distinct from the original glycosyltransferase activity. J
Biol Chem. 277:17002–17008. 2002.
|
|
29.
|
Toki D, Sarkar M, Yip B, Reck F, Joziasse
D, Fukuda M, Schachter H and Brockhausen I: Expression of stable
human O-glycan core 2 beta-1,6-N-acetylglucosaminyltransferase in
Sf9 insect cells. Biochem J. 325:63–69. 1997.PubMed/NCBI
|
|
30.
|
Barbier O, Girard C, Breton R, Bélanger A
and Hum DW: N-glycosylation and residue 96 are involved in the
functional properties of UDP-glucuronosyltransferase enzymes.
Biochemistry. 39:11540–11552. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Christensen LL, Bross P and Ørntoft TF:
Glycosylation of the N-terminal potential N-glycosylation sites in
the human alpha1,3-fucosyltransferase V and -VI (hFucTV and -VI).
Glycoconj J. 17:859–865. 2000. View Article : Google Scholar : PubMed/NCBI
|
